PR Newswire Broadcast Minute for Monday, August 29, 2005

PR Newswire Broadcast Minute for Monday, August 29, 2005

To hear the PR Newswire Broadcast Minute and other MultiVu radio content subscribe to our Podcast at: http://www.prnewswire.com/broadcast/rss/anr-rss.xml

Cell Phone Still Reigns Supreme: Survey Shows CFOs Rank it Most Indispensable Portable Tool

Most people have one technology tool they can't live without. For financial executives, it's the cell phone. In a nationwide survey of chief financial officers by Robert Half, cell phones topped the list as the most indispensable portable technology device, with 44 percent of the response. Laptop computers came in close second, cited by 39 percent of executives polled.

Full story at: http://media.prnewswire.com/en/jsp/main.jsp?resourceid=3020559

Drug May Modify Alzheimer's

A medication under study may help curtail Alzheimer's disease, which afflicts nearly half of those over 85. Initial trials have shown a drug called Ampakine can reduce memory loss by treating the cause instead of the symptoms. Cortex Pharmaceuticals has found Ampakine compounds can combat weakening of brain-cell connections believed to cause memory loss. They may also strengthen brain cells to curb mild cognitive disorders. Second- generation studies are scheduled to determine whether Ampakine can modify Attention Deficit Hyperactivity Disorder and mild to moderate Alzheimer's.

Full story at: http://media.prnewswire.com/en/jsp/main.jsp?resourceid=3015810&packageid=10067

**AUDIO AVAILABLE**

New Research Highlights Important Data on Protecting Bone Health of Women Undergoing Hormonal Treatment for Early Breast Cancer

Full story at: http://media.prnewswire.com/en/jsp/latest.jsp?resourceid=3020689&view=LOCAL

The PR Newswire Broadcast Minute is available by email at no charge to members of the media who sign up for PR Newswire for Journalists, http://www.prnewswire.com/media . For more information, contact Rob Fisher at 408-365-8793 or email rob.fisher@prnewswire.com .

PRNewswire -- Aug. 29

Source: PR Newswire

------- Profile: Ent